Siglec-G represses DAMP-mediated effects on T cells

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Negative regulators of innate immune responses are increasingly recognized.
• The role of suppressors in T cell responses to damage-associated molecular patterns (DAMPs) and their therapeutic potential remain unclear.
• Sialic acid-binding immunoglobulin-like lectin G (Siglec-G) is known to regulate DAMP responses in innate immune cells, but its function in T cells is unknown.

Purpose of the Study:

• To investigate the T cell-autonomous role of Siglec-G in regulating T cell responses.
• To determine if Siglec-G can be targeted to modulate T cell-mediated immunopathology, specifically graft-versus-host disease (GVHD).

Main Methods:

• Utilized genetic knockout and agonist-based approaches to study Siglec-G function.
• Assessed Siglec-G's impact on T cell responses in vitro and in vivo.
• Evaluated the effect of enhancing Siglec-G signaling on GVHD severity and graft-versus-tumor (GVT) effects.

Main Results:

• Siglec-G was found to suppress T cell responses in the presence of certain DAMPs, both in vitro and in vivo.
• Siglec-G plays a critical T cell-autonomous role in modulating the severity of GVHD.
• Enhancing Siglec-G signaling using a CD24Fc fusion protein ameliorated GVHD.

Conclusions:

• Siglec-G acts as a novel negative regulator of T cell responses.
• Targeting Siglec-G signaling presents a potential therapeutic strategy to mitigate GVHD.
• Siglec-G modulation preserves crucial GVT effects, indicating its potential for selective immunomodulation in transplantation settings.